Accelerating and de-risking the development and manufacture of your next-generation therapies, our integrated approach supports the lifecycle of ADC discovery and development including the design and synthesis of payload-linker constructs for ADCs and conjugates.
Offering a comprehensive approach, we use a matrix evaluation and developability approach to streamline the development, scale, and manufacture of your challenging payloads, linkers and payload-linker chemical intermediates for ADCs and other conjugates for your discovery and preclinical programs.
Supporting your candidate ranking and lead selection process, we determine the optimal design of linker payload architecture and profiling in a series of in silico, in vitro and ex vivo activity and safety assessments.
Get in touch